# Enterprise Pharmaceutical Data Platform Architecture

> **Level:** EXPERT · **Module 01/12** · **Goal:** Design Snowflake as a governed, multi-domain enterprise data platform with clear ingestion contracts and tenancy boundaries.

## 1. Concept and mental model

- **Domains:** R&D, clinical operations, manufacturing, quality, supply chain; each has its own data owner and SLAs.
- **Data products:** consumable interfaces with contracts, lineage, documentation, access policy and ownership.
- **Layered architecture:** raw/validated/curated is a design convention, not magic enforcement.
- **Environment isolation:** separate change lifecycles and identities; account separation where regulatory or risk requirements justify it.

**How to reason about it:** Design ingestion as distinct trust zones. Critical batch-release decisions must use an explicitly approved authoritative source and validated transformations, not an informal ad hoc dashboard.

## 2. Pharmaceutical data-engineering scenario

A global pharma business integrates MES batch events, LIMS results, ERP orders and clinical study status into a single analytical ecosystem.

The example is a **synthetic Sanofi-inspired** design, not an assertion about Sanofi internal infrastructure, specifications, vendors or production records. Where the topic touches clinical, quality or manufacturing data, actual production use requires the organization's approved source definitions, access controls and regulatory assessment.

## 3. Practical implementation

The following is a focused working pattern. A few examples intentionally show a configuration sketch rather than a runnable service integration; read the comments and fulfill prerequisites first. Unless otherwise stated, run SQL after creating the `PHARMA_DEMO` schemas from the entry curriculum.

```sql
-- Illustrative domain-oriented schema layout.
CREATE DATABASE IF NOT EXISTS PHARMA_DEMO;
CREATE SCHEMA IF NOT EXISTS PHARMA_DEMO.CLINICAL_RAW;
CREATE SCHEMA IF NOT EXISTS PHARMA_DEMO.MFG_RAW;
CREATE SCHEMA IF NOT EXISTS PHARMA_DEMO.QA_CORE;
CREATE SCHEMA IF NOT EXISTS PHARMA_DEMO.SUPPLY_MART;
-- Document each contract outside SQL:
-- owner, source SLA, grain, retention, criticality, DQ metrics,
-- access classification, replay source, recovery objective.
```

**Execution walkthrough**

1. Read the Snowflake object names, business grain and access assumptions before executing anything.
2. Execute the example only in a disposable DEV environment after satisfying any stated prerequisites.
3. Inspect results against the validation criteria; do not infer correctness from an exit status alone.
4. Repeat with a deliberate duplicate, null, failure or late-arriving input and document the expected behavior.

## 4. Validate the result

**Acceptance check:** Review a new domain against an architecture checklist: owner, data classification, freshness, lineage, data contracts, supported replay, unit costs, and SLA.

Keep at minimum the source record count, authoritative business keys, run timestamp/ID, relevant SQL query IDs or Git SHA, DQ outcome and the reviewer of any exception. For regulated use, follow the approved evidence retention and change-control procedure; these learning exercises are not a validated system by themselves.

## 5. Failure modes and production safeguards

- Centralized privileges granting indiscriminate cross-domain access.
- No identity strategy between vendor-operated and internal feeds.
- Mixing exploratory analytics with validated regulated decision systems.

**Engineering decision:** Federate ownership and standardize platform controls; a common stack does not mean every domain has identical latency or compliance requirements.

**Operational checks:** confirm least-privilege access, idempotency/replay behavior, source-to-target reconciliation, latency/freshness expectations, cost ownership and an actionable alert or runbook. Not every topic needs every control, but omissions should be justified.

## 6. AI-assisted engineering workflow

Use an approved AI coding assistant with a narrow, read-only or sandboxed scope. Example prompt:

> In the hypothetical pharmaceutical project, implement or review **Enterprise Pharmaceutical Data Platform Architecture**. The requirement is: Design Snowflake as a governed, multi-domain enterprise data platform with clear ingestion contracts and tenancy boundaries. Use only synthetic examples and the documented `PHARMA_DEMO` contract. Produce the smallest reviewable SQL/Python/configuration diff, tests that fail on invalid or duplicate input, a source-to-target reconciliation plan, and expected outputs. Identify permissions, cost, freshness, privacy and rollback risks. Never invent proprietary Sanofi details, query unauthorized records, or deploy to production.

**Human review gate:** evaluate the proposed code against the acceptance check above; compare source semantics, query plans/tests as relevant, and explicitly approve any access changes or production operations.

## 7. Exercise

Draw a logical, physical and security architecture for a three-region pharmaceutical reporting rollout; specify which links need regulatory assessment.

**Deliverable:** a short implementation note including assumptions, a code diff, tests and observed results. For a production-shaped exercise, also include a failure-injection test and recovery steps.

## 8. Interview questions

**Q: When would you apply enterprise pharmaceutical data platform architecture?**  
A: A global pharma business integrates MES batch events, LIMS results, ERP orders and clinical study status into a single analytical ecosystem.

**Q: What is the key implementation trade-off?**  
A: Federate ownership and standardize platform controls; a common stack does not mean every domain has identical latency or compliance requirements.

**Q: What are the failure blast radius, permissions, recoverability, and compliance implications?**  
A: Use the described validation and failure checks, collect reproducible evidence, and explain authorization and recovery assumptions.

**Q: What evidence would convince an architecture/security/QA reviewer this is safe?**  
A: State explicit acceptance criteria and test against the intended data/business grain with a restricted deployment identity.

## 9. Memorize

> **Data products are governed contracts, not merely tables.**

## 10. Official reference

- https://docs.snowflake.com/en/user-guide/data-governance

---

**Navigation:** Previous: [Level README](README.md) · Next: [Real-Time Streaming and Kafka](02-real-time-streaming.md) · [All expert topics](README.md)
